Systemic sclerosis & Raynaud's

Autoantibodies and Relapse of Systemic Sclerosis After Autologous Hematopoietic Cell Transplantation

J RheumatolPublished Cohort study

Main finding · CIR by pre-HCT ARA (univariate)Result — go to the resultHazard ratio 0.21

Authors' conclusion

Positive ARA pre-HCT is associated with reduced relapse risk, and post-HCT autoantibodies do not appear to be associated with relapse risk.

Study context

Population
Consecutive evaluable patients with systemic sclerosis (SSc) who underwent autologous hematopoietic cell transplantation (HCT) at a single center, followed for a median of 33 months16 (42%) relapsed
Participants
38 patients
Exposure
Autoantibody-positive vs autoantibody-negative patients (pre-HCT); patients with vs without relapse (post-HCT autoantibody trajectory)
Outcome
Cumulative incidence of relapse by pre- or post-HCT serum levels of SSc-related autoantibodies
Methodological detailssingle-centre, consecutive patients, Autoantibody levels determined by immunoassays
  • Single-centre
  • Consecutive patients
  • Autoantibody levels determined by immunoassays

Main finding

CIR by pre-HCT ARA (univariate)

Hazard ratio

0.21

P = 0.04

As reported in the abstract

Observational data: associations, not effects.

Further findings

OutcomeHRP value
CIR by pre-HCT anti-Ro52, univariateAnti-Ro52 positive vs Anti-Ro52 negative · higher, not statistically significant2.90P = 0.053
Relapse by pre-HCT Ro52, bivariate (adjusted for older age)Not associated with relapse2.21P = 0.16

Cumulative incidence of relapse (CIR) by pre-HCT antitopoisomerase antibody (ATA) (Scl-70) or antinuclear antibody (ANA)

CIR similar in patients positive and negative for ATA or ANA

Post-HCT autoantibody level trajectory

No significant difference between patients with vs without relapse

Original publication

Autoantibodies and Relapse of Systemic Sclerosis After Autologous Hematopoietic Cell Transplantation. J Rheumatol. Published 15 April 2026. doi:10.3899/jrheum.2025-0987

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.